April 30th 2024
Pemivibart will act as an additional preventive option for COVID-19 among moderately-to-severely immunocompromised adult and adolescent patients, who are disproportionally impacted by the condition.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
ASHP Urges Biden to Use Federal Resources, Expand Workforce for COVID-19 Vaccinations
January 20th 2021In a letter to President Joe Biden, ASHP and more than 50 signers called for use of federal resources and expansion of the vaccinator workforce to confront the slow ramping up of COVID-19 vaccinations.